Last reviewed · How we verify

escitalopram oxalate antidepressant — Competitive Intelligence Brief

escitalopram oxalate antidepressant (escitalopram oxalate antidepressant) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

escitalopram oxalate antidepressant (escitalopram oxalate antidepressant) — Weill Medical College of Cornell University.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
escitalopram oxalate antidepressant TARGET escitalopram oxalate antidepressant Weill Medical College of Cornell University marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). escitalopram oxalate antidepressant — Competitive Intelligence Brief. https://druglandscape.com/ci/escitalopram-oxalate-antidepressant. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: